Institution Directory

Clinical trials at Emory University (Winship Cancer Institute)

Sites in Atlanta, GA

Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 11:30 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

1471

Shown on this page

Current sort

Live official records

Conditions: Cystic Fibrosis
Interventions: RCT2100, Placebo, Ivacaftor; Drug · Other
Lead sponsor: ReCode Therapeutics; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 128 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 13
States / cities: Birmingham, Alabama • Tucson, Arizona • Palo Alto, California + 10 more

Conditions: HIV, Risk Behavior, Alcohol Abuse
Interventions: CLT- Concrete text messages, CLT- Abstract text messages, Control messages, No messages, GamePlan Online Program; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 30 Years · Male only
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer, Anatomic Stage III Breast Cancer, Invasive Breast Lobular Carcinoma
Interventions: Endocrine Therapy, Biopsy of breast, Neratinib, Biospecimen Collection, Mammogram, Magnetic Resonance Imaging, Breast Surgery, Ultrasound; Procedure · Drug
Lead sponsor: Vanderbilt-Ingram Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2031
U.S. locations: 5
States / cities: Atlanta, Georgia • Pittsburgh, Pennsylvania • Nashville, Tennessee + 2 more

Conditions: Coronary Artery Disease
Interventions: Not listed
Lead sponsor: Minneapolis Heart Institute Foundation; Other
Eligibility: Not listed
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2030
U.S. locations: 42
States / cities: Phoenix, Arizona • Little Rock, Arkansas • San Diego, California + 31 more

Conditions: Bone Cancer Metastatic
Interventions: Percutaneous Ablation, Radiation Therapy; Device · Radiation
Lead sponsor: Society of Interventional Oncology; Other
Eligibility: 21 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 8
States / cities: San Diego, California • Miami, Florida • Atlanta, Georgia + 4 more

Conditions: Primary Graft Failure
Interventions: FLT imaging and TK1 blood measurements; Drug
Lead sponsor: University of Oklahoma; Other
Eligibility: 4 Years to 80 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 4
States / cities: Atlanta, Georgia • Ann Arbor, Michigan • Cleveland, Ohio + 1 more

Conditions: Anemia, Sickle Cell, Healthy Volunteers
Interventions: BMS-986470, Placebo, Famotidine, Pantoprazole; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
Enrollment: 224 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 19
States / cities: Birmingham, Alabama • La Jolla, California • Oakland, California + 14 more

Conditions: Glioblastoma, IDH-Wildtype
Interventions: Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging, Fluciclovine F18, Gadolinium-Chelate, Magnetic Resonance Spectroscopy, Positron Emission Tomography; Procedure · Other · Drug
Lead sponsor: ECOG-ACRIN Cancer Research Group; Network
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 18
States / cities: Birmingham, Alabama • Los Angeles, California • Jacksonville, Florida + 14 more

Conditions: Systemic Lupus Erythematosus
Interventions: Obexelimab, Placebo; Drug
Lead sponsor: Zenas BioPharma (USA), LLC; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 190 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 32
States / cities: Peoria, Arizona • Fresno, California • Huntington Park, California + 28 more

Conditions: Leukemia, Myelomonocytic, Chronic
Interventions: Pacritinib, Hydroxyurea; Drug
Lead sponsor: Theradex; Industry
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 4
States / cities: Tampa, Florida • Atlanta, Georgia • Rochester, Minnesota + 1 more

Conditions: Chronic Cough (CC), Refractory Chronic Cough, Unexplained Chronic Cough
Interventions: BCS+inactive, BCS+active; Behavioral · Combination Product
Lead sponsor: University of Montana; Other
Eligibility: 18 Years to 99 Years
Enrollment: 135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 3
States / cities: Aurora, Colorado • Atlanta, Georgia • Missoula, Montana

Conditions: Caregivers of People Living With Dementia, Dementia
Interventions: Cognitive Empathy Training, Control Condition, Pre and post intervention blood spot collection, Pre and post intervention MRI session; Behavioral · Procedure
Lead sponsor: Emory University; Other
Eligibility: 50 Years and older
Enrollment: 118 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 3
States / cities: Atlanta, Georgia

About this Emory University (Winship Cancer Institute) institution page

What this page lists: ClinicalTrials.gov records that list Emory University (Winship Cancer Institute) in Atlanta, GA as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status: A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.

Clinical trials at Emory University (Winship Cancer Institute)

Filter and sort this campus

Live official records

A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF

Project SPACE: Testing Daily Text Messages to Reduce Alcohol Use and HIV Risk Behavior

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

Prospective Global Registry for the Study of Chronic Total Occlusion Intervention

A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated With Percutaneous Ablation and Palliative Radiation Therapy

REVEAL Biomarkers of Engraftment After Alternative Donor HSCT

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

A Study of Obexelimab in Patients With Systemic Lupus Erythematosus

Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia

Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough

Effect of Cognitive Empathy Training on Dementia Caregivers

About this Emory University (Winship Cancer Institute) institution page